# ALDX (Aldeyra Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Aldeyra Therapeutics, Inc. reported $43.38M in total assets and a net loss of $19.13M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ALDX
- Markdown: https://convexityos.com/fundamentals/ALDX.md
- SEC CIK: 0001341235
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:00 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001341235&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$20.20M | Operating profit |
| Net Income | FY 2025 | -$19.13M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.32 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | -- | Total debt: $459K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $25.66M | $48.22M | $29.46M | $47.31M | $44.94M | $24.68M | $44.35M | $29.82M | $16.30M | $13.18M |
| **Operating Income** | -$35.27M | -$60.12M | -$42.79M | -$62.68M | -$56.22M | -$36.42M | -$63.07M | -$39.70M | -$22.49M | -$18.70M |
| **EBITDA** | -$35.01M | -$59.87M | -$42.53M | -$62.42M | -$55.96M | -$36.36M | -$62.98M | -$39.63M | -$22.45M | -$18.66M |
| Interest Income | $3.32M | $6.19M | $7.32M | $2.35M | $185K | $292K | $1.54M | $953K | $261K | $102K |
| Interest Expense | $1.91M | $1.93M | $2.07M | $1.69M | $1.74M | $1.90M | $604K | $147K | $113K | $106K |
| Income Before Tax | -- | -- | -- | -- | -$57.78M | -$38.03M | -$62.14M | -$38.89M | -- | -- |
| Income Tax Expense | $0 | $1.0K | $0 | $0 | $0 | -$479K | -$1.31M | $0 | $0 | $0 |
| **Net Income** | -$33.85M | -$55.85M | -$37.54M | -$62.02M | -$57.78M | -$37.55M | -$60.83M | -$38.89M | -$22.34M | -$18.70M |
| Basic EPS | -$0.56 | -$0.94 | -$0.64 | -$1.06 | -$1.07 | -$1.11 | -$2.24 | -$1.79 | -$1.40 | -$1.65 |
| **Diluted EPS** | -$0.56 | -$0.94 | -$0.64 | -$1.06 | -$1.07 | -$1.11 | -$2.24 | -$1.79 | -$1.40 | -$1.65 |
| Basic Shares Outstanding | 60.1M | 59.5M | 58.9M | 58.4M | 54.0M | 34.0M | 27.1M | 21.7M | 15.9M | 11.4M |
| Diluted Shares Outstanding | 60.1M | 59.5M | 58.9M | 58.4M | 54.0M | 34.0M | 27.1M | 21.7M | 15.9M | 11.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $1.84M | $3.48M | $2.41M | $4.30M | $5.43M | $8.51M | $7.42M | $14.63M |
| **Operating Income** | -$4.14M | -$5.85M | -$3.55M | -$6.67M | -$8.00M | -$10.17M | -$10.43M | -$16.58M |
| **EBITDA** | -$3.98M | -$5.78M | -$3.48M | -$6.60M | -$7.94M | -$10.11M | -$10.37M | -$16.51M |
| Interest Income | $374K | $400K | $563K | $682K | $789K | $872K | $981K | $1.24M |
| Interest Expense | $438 | $23 | $469K | $475K | $476K | $471K | $484K | $471K |
| **Net Income** | -$3.76M | -$5.45M | -$3.45M | -$6.46M | -$7.69M | -$9.77M | -$9.93M | -$15.81M |
| Basic EPS | -$0.06 | -$0.09 | -$0.06 | -- | -$0.13 | -$0.16 | -$0.17 | -- |
| **Diluted EPS** | -$0.06 | -$0.09 | -$0.06 | -- | -$0.13 | -$0.16 | -$0.17 | -- |
| Basic Shares Outstanding | 60.4M | 60.3M | 60.3M | -- | 60.1M | 60.0M | 59.9M | -- |
| Diluted Shares Outstanding | 60.4M | 60.3M | 60.3M | -- | 60.1M | 60.0M | 59.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $70.04M | $54.53M | -- | $144.4M | $229.8M | $77.86M | $44.43M | $47.36M | $20.02M | $12.02M |
| Short-Term Investments | $0 | $46.62M | $0 | $29.88M | $0 | $0 | $28.94M | $46.24M | -- | -- |
| **Cash & Short-Term Investments** | $70.04M | $101.2M | -- | $174.3M | $229.8M | $77.86M | $44.43M | $47.36M | $20.02M | $24.90M |
| Other Current Assets | -- | $0 | $0 | $3.24M | $29K | -- | -- | -- | -- | -- |
| **Total Current Assets** | $71.78M | $104.1M | $147.8M | $181.0M | $232.8M | $83.06M | $75.17M | $94.77M | $43.97M | $25.13M |
| Property, Plant & Equipment, Net | $0 | $0 | $5.8K | $19K | $32K | $60K | $148K | $235K | $43K | $56K |
| **Total Non-Current Assets** | $276K | $534K | $517K | $269K | $384K | $293K | $349K | $322K | $209K | $56K |
| **Total Assets** | $72.06M | $104.6M | $148.3M | $181.3M | $233.1M | $83.35M | $75.52M | $95.09M | $44.17M | $25.19M |
| Accounts Payable | $158K | $180K | $1.34M | $134K | $1.02M | $382K | $808K | $3.05M | $1.00M | $275K |
| Short-Term Debt | $15.25M | $31K | $15.15M | $912K | -- | -- | -- | -- | $116K | $78K |
| Deferred Revenue (Current) | $6.00M | $6.00M | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $27.81M | $18.60M | $22.26M | $15.36M | $11.77M | $12.41M | $12.91M | $8.47M | $3.35M | $2.30M |
| Long-Term Debt | $0 | $15.00M | $0 | $14.92M | $15.50M | $11.43M | $14.53M | $16.04M | $1.22M | $1.24M |
| **Total Non-Current Liabilities** | $0 | $15.00M | $6.27M | $14.92M | $15.63M | $11.43M | $14.53M | $0 | $1.22M | $1.24M |
| **Total Liabilities** | $27.81M | $33.60M | $28.53M | $30.28M | $27.40M | $23.84M | $27.44M | $8.47M | $4.57M | $3.54M |
| **Total Debt (incl. Leases)** | $15.53M | $15.30M | $15.66M | $16.08M | $15.86M | $11.67M | $14.75M | $16.04M | $1.34M | $1.32M |
| Common Stock | $60K | $60K | $59K | $59K | $58K | $39K | $29K | $26K | $19K | $13K |
| Retained Earnings | -$484.0M | -$450.1M | -$394.3M | -$356.7M | -$294.7M | -$236.9M | -$199.4M | -$138.5M | -$99.64M | -$77.30M |
| Accumulated Other Comp. Income | $0 | $37K | $0 | -$104K | $0 | $0 | $5.9K | -$9.2K | -$18K | $129 |
| **Total Stockholders' Equity** | $44.25M | $71.00M | $119.8M | $151.0M | $205.7M | $59.51M | $48.08M | $86.62M | $39.60M | $21.65M |
| Total Equity | $44.25M | $71.00M | $119.8M | $151.0M | $205.7M | $59.51M | $48.08M | $86.62M | $39.60M | $21.65M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | -- | $70.04M | $59.34M | $41.24M | $50.35M | $54.53M |
| Short-Term Investments | -- | -- | -- | $0 | $15.96M | $40.68M | $39.71M | $46.62M |
| **Cash & Short-Term Investments** | -- | -- | -- | $70.04M | $75.30M | $81.92M | $90.06M | $101.2M |
| Other Current Assets | -- | -- | -- | -- | -- | -- | $756K | $0 |
| **Total Current Assets** | $42.92M | $47.38M | $66.27M | $71.78M | $77.46M | $84.56M | $92.73M | $104.1M |
| Property, Plant & Equipment, Net | $18K | $21K | -- | $0 | -- | -- | -- | $0 |
| **Total Non-Current Assets** | $463K | $162K | $209K | $276K | $341K | $405K | $467K | $534K |
| **Total Assets** | $43.38M | $47.54M | $66.48M | $72.06M | $77.80M | $84.96M | $93.20M | $104.6M |
| Accounts Payable | $144K | $137K | $141K | $158K | $13K | $1.46M | $346K | $180K |
| Short-Term Debt | $0 | $0 | $15.30M | $15.25M | $15.20M | $15.15M | $0 | $31K |
| Deferred Revenue (Current) | -- | -- | -- | $6.00M | -- | -- | -- | $6.00M |
| **Total Current Liabilities** | $7.88M | $9.66M | $24.33M | $27.81M | $28.48M | $29.53M | $14.29M | $18.60M |
| Long-Term Debt | -- | -- | $0 | $0 | $0 | $0 | $15.10M | $15.00M |
| **Total Non-Current Liabilities** | $280K | $0 | $0 | $0 | $73K | $143K | $15.31M | $15.00M |
| **Total Liabilities** | $8.16M | $9.66M | $24.33M | $27.81M | $28.56M | $29.67M | $29.60M | $33.60M |
| **Total Debt (incl. Leases)** | $459K | $143K | $15.51M | $15.53M | $15.54M | $15.56M | $15.57M | $15.30M |
| Common Stock | $60K | $60K | $60K | $60K | $60K | $60K | $60K | $60K |
| Retained Earnings | -$496.6M | -$492.9M | -$487.4M | -$484.0M | -$477.5M | -$469.8M | -$460.0M | -$450.1M |
| Accumulated Other Comp. Income | -- | -- | -- | $0 | $815 | -$11K | $1.6K | $37K |
| **Total Stockholders' Equity** | $35.22M | $37.89M | $42.16M | $44.25M | $49.24M | $55.29M | $63.60M | $71.00M |
| Total Equity | $35.22M | $37.89M | $42.16M | $44.25M | $49.24M | $55.29M | $63.60M | $71.00M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$33.85M | -$55.85M | -$37.54M | -$62.02M | -$57.78M | -$37.55M | -$60.83M | -$38.89M | -$22.34M | -$18.70M |
| Depreciation & Amortization | $252K | $250K | $263K | $259K | $264K | $56K | $96K | $71K | $38K | $36K |
| Stock-Based Compensation | $6.09M | $7.97M | $5.75M | $8.29M | $7.11M | $7.08M | $8.08M | $4.14M | $2.71M | $2.76M |
| Change in Payables | -$22K | -$1.16M | $1.20M | -$886K | $638K | -$427K | -$2.85M | $2.05M | $726K | -$576K |
| **Operating Cash Flow** | -$33.35M | -$43.21M | -$30.33M | -$56.64M | -$42.56M | -$37.49M | -$44.98M | -$29.86M | -$19.22M | -$15.15M |
| Capital Expenditure | -- | -- | $0 | -$16K | -$7.8K | -- | -$9.5K | -$263K | -$25K | -$12K |
| **Free Cash Flow** | -- | -- | -$30.33M | -$56.65M | -$42.56M | -- | -$44.99M | -$30.12M | -$19.25M | -$15.16M |
| Purchases of Investments | -$40.26M | -$96.92M | $0 | -$92.94M | $0 | -$5.78M | -- | -- | -- | -- |
| **Investing Cash Flow** | $47.74M | -$44.92M | $30.00M | -$29.95M | -$7.8K | $29.02M | $18.48M | -$23.34M | -$10.20M | -$225K |
| Common Stock Issued | -- | -- | -- | $0 | $189.8M | $40.72M | $7.89M | $81.84M | $37.47M | $12.65M |
| **Financing Cash Flow** | $1.12M | -$171K | -$1.27M | $1.22M | $194.5M | $41.90M | $23.58M | $80.53M | $37.43M | $12.74M |
| **Net Change in Cash** | $15.51M | -$88.30M | -$1.60M | -$85.37M | $151.9M | $33.43M | -$2.93M | $27.33M | $8.01M | -$2.63M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.76M | -$5.45M | -$3.45M | -$6.46M | -$7.69M | -$9.77M | -$9.93M | -$15.81M |
| Depreciation & Amortization | $155K | $71K | $67K | $65K | $64K | $62K | $61K | $64K |
| Stock-Based Compensation | $1.11M | $1.64M | -$988K | $1.09M | $2.58M | $197K | $2.22M | $1.26M |
| Change in Payables | $7.0K | -$3.9K | -$17K | $145K | -$1.02M | $683K | $166K | -$6.5K |
| **Operating Cash Flow** | -$4.12M | -$4.59M | -$5.11M | -$5.30M | -$7.02M | -$8.56M | -$12.47M | -$12.04M |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | -$24.55M | -$15.71M | -$21.56M |
| **Investing Cash Flow** | $0 | -$23K | $0 | $16.00M | $25.00M | -$554K | $7.29M | -$1.56M |
| **Financing Cash Flow** | $9.7K | -$15.30M | $71K | $0 | $121K | $0 | $1.00M | $7.8K |
| **Net Change in Cash** | -$4.11M | -$19.91M | -$5.04M | $10.70M | $18.10M | -$9.11M | -$4.18M | -$13.59M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -76.5% | -78.7% | -31.3% | -41.1% | -28.1% | -63.1% | -126.5% | -44.9% | -56.4% | -86.4% |
| Return on Assets (ROA) | -47.0% | -53.4% | -25.3% | -34.2% | -24.8% | -45.1% | -80.5% | -40.9% | -50.6% | -74.2% |
| Current Ratio | 2.58x | 5.59x | 6.64x | 11.78x | 19.77x | 6.69x | 5.82x | 11.18x | 13.11x | 10.93x |
| Quick Ratio | 2.52x | 5.44x | -- | 11.35x | 19.52x | 6.27x | 3.44x | 5.59x | 5.97x | 10.83x |
| Debt to Equity | 0.35x | 0.22x | 0.13x | 0.11x | 0.08x | 0.20x | 0.31x | 0.19x | 0.03x | 0.06x |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -- | -- | -- | -104.4% | -- | -- |
| 10Y Net Income / Share Growth | -- | -- | -101.6% | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -54.3% | -60.8% | -64.9% | -76.5% | -87.7% | -91.6% | -90.7% | -78.7% |
| Return on Assets (ROA) | -44.1% | -48.5% | -41.2% | -47.0% | -55.5% | -59.6% | -61.9% | -53.4% |
| Current Ratio | 5.45x | 4.91x | 2.72x | 2.58x | 2.72x | 2.86x | 6.49x | 5.59x |
| Quick Ratio | -- | -- | -- | 2.52x | 2.64x | 2.77x | 6.30x | 5.44x |
| Debt to Equity | 0.01x | 0.00x | 0.37x | 0.35x | 0.32x | 0.28x | 0.24x | 0.22x |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -2505.3% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
